Recent Finacing
Recent Raise
Immunophotonics is a clinical-stage biotech developing IP-001, a proprietary glycan polymer administered with tumor ablation to retain antigens, recruit/activate antigen-presenting cells, and stimulate adaptive anti-tumor immunity.
